JMI Laboratories has over two decades of extensive experience in performing surveillance studies in support of new drug applications or to satisfy post-marketing commitments.
JMI Laboratories is a GLP compliant and CLIA certified reference microbiology laboratory that provides support for the development of new investigational compounds
We provide clients with full molecular characterization of isolates, including epidemiological typing as well as their resistance and virulence genes.
We provide clients comprehensive GCLP support for bacterial and fungal phase I – IV clinical trials.
We offer clients full laboratory support for genetic investigations of the entire microbiome.
We can help you disseminate your study results to the clinical and scientific community through our medical writing services.
Chief Executive Officer
Mariana Castanheira, Ph.D.
Chief Scientific Officer
Helio S. Sader, M.D., Ph.D.
Senior Director for Microbiology and Surveillance
Dee Shortridge, Ph.D.
Senior Director for Antimicrobial Development
Rodrigo E. Mendes, Ph.D.
Director for Molecular and Microbiology
Cecilia G. Carvalhaes, M.D., Ph.D.
Associate Director for Clinical Microbiology
Leonard Duncan, Ph.D.
Associate Director for Antimicrobial Development
Michael D. Huband
Associate Director of Surveillance and New Drug Development
Michael A. Pfaller, M.D.